Updates matching "Access to Biomarker Testing"

AUGUSTA, ME – JANUARY 29, 2024 – On Tuesday, January 30, Maine’s Joint Standing Committee on Health Coverage, Insurance and Financial Services will consider LD 1577. The American Cancer Society Cancer Action Network (ACS CAN) urges Committee members to support the bill, which aims to expand coverage for biomarker testing—when

Indiana Must Do Better to Reduce the Burden of Cancer

ALBANY, NY – JANUARY 17, 2024 – With her budget address yesterday, the character of Governor Hochul’s 2024 legislative agenda comes into focus, leading advocates to react and highlight opportunities to reduce the cancer burden in New York in 2024. The following is a statement from the American Cancer Society

CHARLESTON, W. Va. –Delegate Steve Westfall recently introduced legislation that would increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. Despite its benefits, access to biomarker testing has not kept pace with the rate of innovation due to several barriers, including lack

TRENTON, NJ – JANUARY 12, 2024 – As lawmakers dive into the 2024 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on New Jerseyans, securing each resident equal opportunity to prevent, detect, treat and survive

As lawmakers dive into the 2024 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Buckeyes.

As lawmakers dive into the 2024 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Hoosiers.

DES MOINES, Iowa - Statement from Jackie Cale, American Cancer Society Cancer Action Network (ACS CAN) Iowa government relations director: “As lawmakers dive into the 2024 legislative session, ACS CAN urges legislators to prioritize passing legislation to ease the burden of cancer on Iowans. According to the 2023 Cancer

As Washington legislators convene for the new session, it is crucial for them to prioritize cancer patients and cancer care by assuring all residents have ready access to biomarker testing.